ALPHA-INTERFERON ACTIVATES THE NATURAL-KILLER SYSTEM IN PATIENTS WITH HAIRY-CELL LEUKEMIA
- 1 July 1986
- journal article
- research article
- Vol. 68 (1) , 293-296
Abstract
To elucidate the mechanisms of .alpha.-interferon''s (.alpha.-INF) therapeutic effect on clinical and laboratory findings in hairy cell leukemia, we sequentially monitored different immunologic parameters in three patients treated with recombinant .alpha.-INF. The most evident effect of this treatment on the immune system was the recovery of natural killer (NK) cell in vitro activity of peripheral blood lymphocytes, which was severely impaired before therapy. In particular, NK function began to improve after 3 months, and a complete recovery was obtained after 6 months in all cases. This increase parallels the improvement in clinical and laboratory findings.This publication has 24 references indexed in Scilit:
- Recombinant Leukocyte A Interferon: An Active Agent in Advanced Cutaneous T-Cell LymphomasAnnals of Internal Medicine, 1984
- Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia.Proceedings of the National Academy of Sciences, 1983
- Interleukin 2 dependence of human natural killer (NK) cell activity.The Journal of Immunology, 1983
- SEVERE DEFICIENCY OF NATURAL-KILLER ACTIVITY IN THE PERIPHERAL-BLOOD OF PATIENTS WITH HAIRY-CELL LEUKEMIA1983
- Interferon and natural killer activity in multiple myeloma. Lack of correlation between interferon-induced enhancement of natural killer activity and clinical response to human interferon-αInternational Journal of Cancer, 1982
- Systemic Administration of Human Leukocyte Interferon to Melanoma Patients. I. Effects on Natural Killer Function and Cell Populations2, 3JNCI Journal of the National Cancer Institute, 1982
- Stimulation by interferon of induction of differentiation of human promyelocytic leukemia cellsBiochemical and Biophysical Research Communications, 1982
- A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1).The Journal of Immunology, 1981
- Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant LymphomaAnnals of Internal Medicine, 1980
- Leukemic ReticuloendotheliosisBlood, 1958